• Orchestra BioMed disclosed a change in beneficial ownership by Darren Sherman, President and Chief Operating Officer.
• Sherman’s direct holdings fell by 4,925 common shares at USD 5.26, leaving 1,149,402 shares.
• A separate 2,000-share common stock purchase at USD 5.33 was reported as indirectly held by his son.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-103209), on August 28, 2026, and is solely responsible for the information contained therein.